v3.26.1
Condensed Statement of Changes in Shareholders' Equity (Deficit) (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Share Subscription Receivable [Member]
Retained Earnings [Member]
Total
Balance at Sep. 28, 2025
Balance, shares at Sep. 28, 2025 [1]        
Ordinary shares issued to sponsor $ 436 24,564 (25,000)
Ordinary shares issued to sponsor, shares [1] 4,362,069        
Net income (loss)   (24,487) (24,487)
Balance at Oct. 31, 2025 $ 436 24,564 (25,000) (24,487) (24,487)
Balance, shares at Oct. 31, 2025 [1] 4,362,069        
Net income (loss) (46,172) (46,172)
Balance at Jan. 31, 2026 $ 436 24,564 (25,000) (70,659) (70,659)
Balance, shares at Jan. 31, 2026 [1] 4,362,069        
Balance at Oct. 31, 2025 $ 436 24,564 (25,000) (24,487) (24,487)
Balance, shares at Oct. 31, 2025 [1] 4,362,069        
Net income (loss)         243,936
Balance at Apr. 30, 2026 $ 469 290,469 219,449 510,387
Balance, shares at Apr. 30, 2026 [1] 4,694,069        
Balance at Jan. 31, 2026 $ 436 24,564 (25,000) (70,659) (70,659)
Balance, shares at Jan. 31, 2026 [1] 4,362,069        
Net income (loss) 290,108 290,108
Issuance of representative shares $ 3 (3)
Issuance of representative shares, shares [1] 28,000        
Sales of private placement units $ 30 3,039,970 3,040,000
Sales of private placement units, shares [1] 304,000        
Issuance of public rights, net of issuance costs 2,643,203 2,643,203
Accretion of ordinary shares subject to redemption value (5,417,265) (5,417,265)
Collection of share capital receivable 25,000 25,000
Balance at Apr. 30, 2026 $ 469 $ 290,469 $ 219,449 $ 510,387
Balance, shares at Apr. 30, 2026 [1] 4,694,069        
[1] On March 30, 2026, the underwriter partially exercised their over-allotment option, resulting in 455,173 founder shares no longer subject to forfeiture.